ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 136 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $796,000 | -38.2% | 9,310 | -16.2% | 0.32% | -38.4% |
| Q2 2018 | $1,288,000 | +8.1% | 11,115 | -24.5% | 0.52% | +2.4% |
| Q1 2018 | $1,191,000 | +1.7% | 14,715 | -26.2% | 0.51% | +11.1% |
| Q4 2017 | $1,171,000 | -1.8% | 19,950 | -21.8% | 0.46% | -9.5% |
| Q3 2017 | $1,193,000 | +0.5% | 25,500 | -22.7% | 0.51% | -0.4% |
| Q2 2017 | $1,187,000 | +16.8% | 33,000 | 0.0% | 0.51% | +7.6% |
| Q1 2017 | $1,016,000 | -8.1% | 33,000 | 0.0% | 0.47% | -17.3% |
| Q4 2016 | $1,106,000 | +26.0% | 33,000 | 0.0% | 0.57% | +28.9% |
| Q3 2016 | $878,000 | – | 33,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |